473 related articles for article (PubMed ID: 17667569)
1. Immunoglobulin E antibodies to rocuronium: a new diagnostic tool.
Ebo DG; Venemalm L; Bridts CH; Degerbeck F; Hagberg H; De Clerck LS; Stevens WJ
Anesthesiology; 2007 Aug; 107(2):253-9. PubMed ID: 17667569
[TBL] [Abstract][Full Text] [Related]
2. Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide.
Ebo DG; Bridts CH; Hagendorens MM; Mertens CH; De Clerck LS; Stevens WJ
Allergy; 2006 Aug; 61(8):935-9. PubMed ID: 16867045
[TBL] [Abstract][Full Text] [Related]
3. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents.
Harboe T; Johansson SG; Florvaag E; Oman H
Allergy; 2007 Dec; 62(12):1445-50. PubMed ID: 17983379
[TBL] [Abstract][Full Text] [Related]
4. IgE-mediated allergy to pholcodine and cross-reactivity to neuromuscular blocking agents: Lessons from flow cytometry.
Leysen J; De Witte L; Sabato V; Faber M; Hagendorens M; Bridts C; De Clerck L; Ebo D
Cytometry B Clin Cytom; 2013 Mar; 84(2):65-70. PubMed ID: 23355309
[TBL] [Abstract][Full Text] [Related]
5. National pholcodine consumption and prevalence of IgE-sensitization: a multicentre study.
Johansson SG; Florvaag E; Oman H; Poulsen LK; Mertes PM; Harper NJ; Garvey LH; Gerth van Wijk R; Metso T; Irgens A; Dybendal T; Halsey J; Seneviratne SL; Guttormsen AB
Allergy; 2010 Apr; 65(4):498-502. PubMed ID: 19796197
[TBL] [Abstract][Full Text] [Related]
6. Cross-reactivity of rocuronium with other neuromuscular blocking agents.
Laxenaire MC; Gastin I; Moneret-Vautrin DA; Widmer S; Guéant JL
Eur J Anaesthesiol Suppl; 1995 Sep; 11():55-64. PubMed ID: 8557008
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively.
Florvaag E; Johansson SG; Oman H; Venemalm L; Degerbeck F; Dybendal T; Lundberg M
Acta Anaesthesiol Scand; 2005 Apr; 49(4):437-44. PubMed ID: 15777289
[TBL] [Abstract][Full Text] [Related]
8. Influence of total serum IgE levels on the in vitro detection of beta-lactams-specific IgE antibodies.
Vultaggio A; Matucci A; Virgili G; Rossi O; Filì L; Parronchi P; Romagnani S; Maggi E
Clin Exp Allergy; 2009 Jun; 39(6):838-44. PubMed ID: 19400911
[TBL] [Abstract][Full Text] [Related]
9. Pholcodine stimulates a dramatic increase of IgE in IgE-sensitized individuals. A pilot study.
Florvaag E; Johansson SG; Oman H; Harboe T; Nopp A
Allergy; 2006 Jan; 61(1):49-55. PubMed ID: 16364156
[TBL] [Abstract][Full Text] [Related]
10. Differentiating the cellular and humoral components of neuromuscular blocking agent-induced anaphylactic reactions in patients undergoing anaesthesia.
Aalberse RC; Kleine Budde I; Mulder M; Stapel SO; Paulij W; Leynadier F; Hollmann MW
Br J Anaesth; 2011 May; 106(5):665-74. PubMed ID: 21414980
[TBL] [Abstract][Full Text] [Related]
11. Allergy to rocuronium: from clinical suspicion to correct diagnosis.
Leysen J; Bridts CH; De Clerck LS; Vercauteren M; Lambert J; Weyler JJ; Stevens WJ; Ebo DG
Allergy; 2011 Aug; 66(8):1014-9. PubMed ID: 21375539
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of morphine, pholcodine and poppy seed IgE assays in drug-abusers and allergic people.
Armentia A; Ruiz-Muñoz P; Quesada JM; Postigo I; Herrero M; Martín-Gil FJ; Gonzalez-Sagrado M; Martín B; Castrodeza J
Allergol Immunopathol (Madr); 2013; 41(1):37-44. PubMed ID: 21940094
[TBL] [Abstract][Full Text] [Related]
13. Failure to investigate anaesthetic anaphylaxis resulting in a preventable second anaphylactic reaction.
Pedersen AF; Green S; Rose MA
Anaesth Intensive Care; 2012 Nov; 40(6):1053-5. PubMed ID: 23194216
[TBL] [Abstract][Full Text] [Related]
14. Morphine and pholcodine-specific IgE have limited utility in the diagnosis of anaphylaxis to benzylisoquinolines.
Rose MA; Anderson J; Green SL; Yun J; Fernando SL
Acta Anaesthesiol Scand; 2018 May; 62(5):628-634. PubMed ID: 29368335
[TBL] [Abstract][Full Text] [Related]
15. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
Mertes PM; Moneret-Vautrin DA; Leynadier F; Laxenaire MC
Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568
[TBL] [Abstract][Full Text] [Related]
16. IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market.
Florvaag E; Johansson SG; Irgens Å; de Pater GH
Allergy; 2011 Jul; 66(7):955-60. PubMed ID: 21241314
[TBL] [Abstract][Full Text] [Related]
17. Measurement of pholcodine-specific IgE in addition to morphine-specific IgE improves investigation of neuromuscular blocking agent anaphylaxis.
Anderson J; Green S; Capon M; Krupowicz B; Li J; Fulton R; Fernando SL
Br J Anaesth; 2020 Dec; 125(6):e450-e452. PubMed ID: 32600804
[No Abstract] [Full Text] [Related]
18. IgE-mediated anaphylactic reactions to neuromuscular blocking agents: can they be prevented?
Florvaag E; Johansson SG
Curr Allergy Asthma Rep; 2008 Sep; 8(5):375-6. PubMed ID: 18682099
[No Abstract] [Full Text] [Related]
19. [Allergy investigations after two cases of adverse reactions to a neuromuscular blocking agent and management for subsequent general anaesthesia].
Louvier N; Chomel A; Collet E; Juniot A; Pillet M
Ann Fr Anesth Reanim; 2003 Jan; 22(1):54-7. PubMed ID: 12738022
[TBL] [Abstract][Full Text] [Related]
20. No consumption of IgE antibody in serum during allergic drug anaphylaxis.
Guttormsen AB; Johansson SG; Oman H; Wilhelmsen V; Nopp A
Allergy; 2007 Nov; 62(11):1326-30. PubMed ID: 17714550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
